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Longitudinal growth of long bones occurs 
through endochondral ossifi  cation, which is ac-
companied by chondrocyte diff  erentiation (1). 
Initially, mesenchymal cells are committed to 
become cartilage cells and condense into com-
pact nodules and diff  erentiate into chondrocytes. 
Chondrocytes then proliferate rapidly to form 
a model for the bone. As chondrocytes di-
vide, they form a columnar structure and secrete 
cartilage-specifi  c extracellular matrix proteins, 
such as type II collagen and aggrecan (1). Chon-
drocytes then stop dividing and increase their 
volume dramatically, becoming hypertrophic (2). 
These large chondrocytes alter the matrix by 
  secreting type X collagen and increased levels of 
fi  bronectin to promote mineralization by calcium 
carbonate. Hypertrophic chondrocytes, which 
also produce matrix metalloproteinase (MMP) 13, 
die by apoptosis (1–3). Such events occur in a 
closed avascular area, suggesting that they are, 
at least in part, cell-autonomously regulated. 
Because inappropriate chondrocyte hypertrophy 
causes skeletal growth abnormalities such as dwarf-
ism, control of hypertrophy is critical for normal 
longitudinal bone growth (4–6). Hypertrophic 
chondrocytes express vascular endothelial growth 
factor, stimulating blood vessels to invade the 
cartilage model (2). Groups of cells surround-
ing the cartilage model diff  erentiate into osteo-
blasts, which begin forming bone matrix on the 
partially degraded cartilage. However, signals 
triggering chondrocyte hypertrophy have not 
been identifi  ed.
Chondrocyte hypertrophy is part of a nor-
mal diff  erentiation process in which cells un-
dergo apoptosis (1, 2). Reactive oxygen species 
(ROS), which induce apoptosis in cells such 
as neurons (7), play critical roles in cell regula-
tion, sometimes as second messengers (8, 9). 
ROS, including superoxide anion (O2−), hy-
droxyl radical (OH), and hydrogen peroxide 
(H2O2), which can diff  use through membranes, 
are by-products of cellular oxidative metabo-
lism. Nitrogen-containing oxidants such as ni-
tric oxide are called reactive nitrogen species. 
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Chondrocyte hypertrophy during endochondral ossifi  cation is a well-controlled process 
in which proliferating chondrocytes stop proliferating and differentiate into hypertrophic 
chondrocytes, which then undergo apoptosis. Chondrocyte hypertrophy induces angiogenesis 
and mineralization. This step is crucial for the longitudinal growth and development of long 
bones, but what triggers the process is unknown. Reactive oxygen species (ROS) have been 
implicated in cellular damage; however, the physiological role of ROS in chondrogenesis 
is not well characterized. We demonstrate that increasing ROS levels induce chondrocyte 
hyper  trophy. Elevated ROS levels are detected in hypertrophic chondrocytes. In vivo and in 
vitro treatment with N-acetyl cysteine, which enhances endogenous antioxidant levels and 
protects cells from oxidative stress, inhibits chondrocyte hypertrophy. In ataxia telangiectasia 
mutated (Atm)–defi  cient (Atm−/−) mice, ROS levels were elevated in chondrocytes of growth 
plates, accompanied by a proliferation defect and stimulation of chondrocyte hypertrophy. 
Decreased proliferation and excessive hypertrophy in Atm−/− mice were also rescued by 
antioxidant treatment. These fi  ndings indicate that ROS levels regulate inhibition of prolif-
eration and modulate initiation of the hypertrophic changes in chondrocytes.
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ROS are also generated by several types of stimulation other 
than cell metabolism, such as phagocytosis (10). Excess ROS 
can overwhelm a cell’s antioxidant scavenging capacity, caus-
ing oxidative damage to DNA, lipids, and proteins, as well as 
concomitant cellular damage (11). Therefore, the regulation 
of intracellular ROS is crucial for cell survival.
Ataxia telangiectasia mutated (ATM) functions in oxida-
tive defense, and mice with Atm loss of function show pre-
mature aging caused by defects in DNA repair (12, 13). We 
previously showed that hematopoietic stem cell function was 
suppressed through elevation of ROS levels, p38 mitogen-
activated protein kinase (MAPK) phosphorylation, and p16INK4A 
expression in ATM-defi  cient mice (14). In that study, the 
administration of N-acetyl cysteine (NAC), an antioxidant (15), 
rescued stem cell function, indicating that ATM regulates 
intracellular H2O2 levels (14).
In this paper, we demonstrate that increased ROS levels 
were seen in hypertrophic chondrocytes, and antioxidant 
treatment blocked chondrocyte hypertrophy and rescued the 
inhibited proliferation in chondrocytes. In vitro treatment of 
chondrogenic cells with oxidants directly induced chondro-
cyte hypertrophy, and induction was inhibited by NAC. ROS 
activated extracellular signal-regulated kinase (ERK) and p38 
MAPK pathways in chondrogenic cells, indicating that ROS 
transduce a diff  erentiation signal in those cells. Higher levels 
of ROS were detected in the chondrocytes of growth plates in 
Atm−/− mice compared with wild types. Signifi  cant decreases 
in proliferation and excessive hypertrophy were observed 
in Atm−/− growth plates, changes rescued by in vivo NAC 
treatment. Thus, increasing ROS levels during chondrogenesis 
inhibit proliferation and initiate chondrocyte hypertrophy in 
growth plates.
RESULTS
Increased ROS in hypertrophic chondrocytes
We began by asking whether ROS levels were elevated in vivo 
during chondrogenesis by undertaking dihydroethidium stain-
ing of wild-type E17.5 mouse embryos. Dihydroethidium is 
intracellularly oxidized by ROS and converted to fl  uorescent 
ethidium (Eth). Eth can bind to chromosomal DNA, yielding 
Eth-DNA; therefore, ROS can be detected by nuclear Eth-
DNA accumulation. Higher levels of intracellular ROS were 
detected in prehypertrophic and hypertrophic chondrocytes 
compared with proliferating chondrocytes or surrounding tis-
sues (Fig. 1 A). To further analyze ROS levels during chon-
drogenesis, the chondrogenic cell line ATDC5 was cultured 
in diff  erentiation medium containing insulin, transferrin, and 
sodium selenite, as previously described (16). Under this culture 
condition, ATDC5 cells effi   ciently undergo a chondrogenic 
diff  erentiation program similar to that observed in vivo (17). 
Hypertrophic chondrocyte markers such as type X collagen and 
mmp13, as well as increased intracellular levels of ROS de-
tected by dichlorodihydrofl  uorescein diacetate (DCF-DA), 
were induced in ATDC5 cells cultured in diff  erentiation 
medium for 2 wk (Fig. 1, B and C). We examined the ef-
fect of NAC treatment on intracellular ROS levels during 
chondrocyte hypertrophy. After NAC treatment, the higher 
intracellular ROS levels in ATDC5 cells cultured in diff  erentia-
tion medium were eff  ectively reduced to levels comparable to 
those seen in cells cultured in control medium (Fig. 1 C). Basal 
ROS levels in cells cultured even in control medium gradually 
increased and were NAC resistant (Fig. 1 C), suggesting the 
existence of DCF-sensitive oxidants other than H2O2. Because 
NAC is a glutathione precursor, which reduces intracellu-
lar H2O2 levels, diff  erentiation medium may specifi  cally 
elevate intracellular H2O2. Nicotinamide adenine dinucleotide 
  phosphate–oxidase–1 generates superoxide and is thus responsi-
ble for ROS production (10). H2O2 is generated via dismutation 
of superoxide. We found that nox1 expression was highly 
  induced in ATDC5 cells cultured in diff  erentiation medium 
compared with control medium (Fig. S1, available at http://
www.jem.org/cgi/content/full/jem.20062525/DC1), suggest-
ing that diff  erentiation signals induce expression of an ROS-
generating enzyme. Interestingly, nox1 expression in ATDC5 
cells cultured in diff  erentiation medium was reduced by anti-
oxidant treatment (Fig. S1). Thus, H2O2 signals may induce 
Figure 1.  ROS are elevated in hypertrophic chondrocyte zones. 
(A) Forelimbs of E17.5 embryos were stained with dihydroethidium and 
observed under a phase contrast (a) or confocal microscope (b). Prolifer-
ating and hypertrophic chondrocyte zones were morphologically identi-
fi  ed under the phase contrast microscope (a). P, proliferating chondrocyte 
zone; H, prehypertrophic and hypertrophic chondrocyte zone. Bar, 
100 μm. (B) ATDC5 cells were cultured in differentiation medium for 
1 or 2 wk, and RT-PCR analysis of the hypertrophic markers type X collagen 
and mmp13 and the internal control, β-actin, was undertaken. Data 
representative of at least three repeats are shown. (C) ATDC5 cells were 
cultured in differentiation medium (open squares), control medium 
(open circles), or differentiation medium plus antioxidant NAC (open 
triangles) for 1 or 2 wk, and intracellular ROS concentrations were deter-
mined by DCF-DA staining. Results are shown as mean fold increases ± 
SD in intracellular ROS compared with cells cultured in control 
medium. *, P < 0.05.JEM VOL. 204, July 9, 2007  1615
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expression of ROS-generating enzymes, which in turn stimulate 
chondrocyte hypertrophy by increasing ROS levels.
Elevated ROS stimulate chondrocyte hypertrophy in vitro
We next examined the eff  ect of increased ROS on chondro-
cyte hypertrophy by manipulating intracellular ROS with NAC. 
Hypertrophic chondrocytes were detected in carti  lage nod-
ules, the cellular condensations formed in cultures of ATDC5 
cells (17). To determine whether hypertrophic changes in 
chondrocytes are inhibited by reducing ROS, chondrocyte 
nodules were analyzed in the presence or absence of NAC 
(Fig. 2 A). Hypertrophic chondrocytes detected as type X 
collagen–positive cells were more eff  ectively induced in the 
nodules by diff  erentiation medium compared with control 
medium, and such hypertrophic changes were inhibited by 
NAC treatment. However, there was a recovery in the for-
mation of type X collagen–positive cell–containing nodules 
even after NAC treatment at 3 and 4 wk of culture. This is 
possibly caused by an elevation in the levels of basal oxidants 
resistant to NAC, as shown in Fig. 1 C.
It has been reported that mmp13 and type X collagen are late 
hypertrophic chondrocyte diff  erentiation markers, and their 
expression is not detected in proliferating chondrocyte zones in 
vivo (2, 3). Runx2 is a transcription factor essential for osteo-
blast diff  erentiation, and Runx2-defi  cient mice show defective 
hypertrophic chondrocyte maturation, whereas forced Runx2 
expression induces chondrocyte  hypertrophy (5, 18). To eval-
uate chondrocyte hypertrophy in ATDC5 cells cultured 
in various conditions with or without NAC, we examined 
the expression of hypertrophic chondrocyte markers such as 
mmp13, type X collagen, and runx2 by RT-PCR. Expression of 
mmp13, type X collagen, and runx2 was reduced by NAC treat-
ment, and the hypertrophic changes in chondrocytes were 
inhibited by reducing ROS (Fig. 2 B). Again, there was a 
recovery in expression of these genes at late culture stages 
after NAC treatment.
Figure 2.  Hypertrophic changes are associated with elevated ROS. 
(A, top) ATDC5 cells cultured in control medium (a), differentiation me-
dium (b), or differentiation medium plus NAC (c) for 3 wk were stained 
using rabbit anti–type X collagen antibody, followed by Alexa Fluor 488–
conjugated anti–rabbit Ig antibody, and observed under a fl  uorescence 
microscope. (bottom) Data are mean numbers ± SD of type X collagen–
positive hypertrophic chondrocyte–containing nodules. Bar, 50 μm. 
(B) ATDC5 cells were cultured in differentiation medium, control medium, 
or differentiation medium plus antioxidant NAC for 1–4 wk, and the ex-
pression of mmp13, type X collagen, runx2, and β-actin was determined 
by RT-PCR.1616  ROS REGULATE CHONDROGENESIS | Morita et al.
Figure 3.  Elevated ROS stimulate chondrocyte hypertrophy in 
vivo. (A) Three mice were treated subcutaneously with PBS and three 
were treated with NAC (1 g/kg, every 2 d) for 2 wk from the day of birth, 
and intracellular ROS concentration was evaluated by dihydroethidium 
staining in growth plates. Representative data are shown. Growth plates 
are shown between the dotted lines. (right) Data are mean relative con-
centrations ± SD of ROS in chondrocytes in mice treated with NAC com-
pared with PBS-treated mice. A reduction of intracellular ROS in 
chondrocytes by NAC treatment was observed. *, P < 0.01. Bar, 100 μm. 
(B) Three mice were treated subcutaneously with PBS and three were 
treated with NAC (1 g/kg, every 2 d) for 3 wk from the day of birth, and 
chondrocyte hypertrophy was analyzed by Alcian blue staining. The 
hypertrophic zone (H) was reduced in NAC-treated compared with PBS-
treated mice. (left) Representative data are shown. (right) Data are mean 
relative lengths ± SD of the hypertrophic zone in growth plates treated 
with NAC for 3 wk compared with that of PBS-treated mice. *, P < 0.01. 
Bar, 50 μm. (C) Three mice were treated subcutaneously with PBS and 
three were treated with NAC (1 g/kg, every 2 d) for 3 wk from the day of 
birth, and chondrocyte proliferation was evaluated by BrdU staining. 
TOTO3 was used as a nuclear stain. (left) Representative data are shown. JEM VOL. 204, July 9, 2007  1617
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Elevated ROS stimulate chondrocyte hypertrophy in vivo
To analyze the role of ROS in chondrocyte hypertrophy 
in vivo, we analyzed chondrogenesis in mice treated with 
NAC. To do so, we injected NAC into mice every other day 
from the day of birth until 2 or 3 wk of age, when animals 
were analyzed. ROS levels in growth-plate chondrocytes 
were eff  ectively reduced by this treatment (Fig. 3 A). To 
analyze chondrocyte hypertrophy in growth plates treated 
with NAC, proteoglycans were stained by Alcian blue or 
Safranin-O, as previously described (19, 20). Proteoglycans are 
mainly produced in proliferating chondrocytes and down-
regulated in hypertrophic chondrocytes. NAC treatment 
reduced the size of the hypertrophic chondrocyte zone in 
growth plates (Fig. 3 B). Interestingly, the proteoglycan syn-
thesis indicated by Alcian blue staining was up-regulated by 
NAC treatment (Fig. 3 B), and the reduced hypertrophy and 
up-regulated proteoglycan production were confi  rmed by 
Safranin-O staining (Fig. S2, available at http://www.jem
.org/cgi/content/full/jem.20062525/DC1). 
The number of BrdU-positive proliferating cells also in-
creased in growth-plate chondrocytes after NAC treatment 
(Fig. 3 C). Chondrocyte hypertrophy induces vascular endo-
thelial growth factor expression, resulting in angiogenesis, and 
the hypertrophic chondrocytes then undergo apoptosis. NAC 
administration every other day suppressed growth of endothe-
lial cells, as detected by platelet-endothelial cell adhesion mol-
ecule PECAM staining (Fig. 3 D). The number of apoptotic 
cells was also reduced by this treatment (Fig. S3 A, available at 
http://www.jem.org/cgi/content/full/jem.20062525/DC1).
Treatment of ATDC5 cells with H2O2 signifi  cantly re-
duced the number of cells, a change abolished by addition of 
NAC to the culture medium (Fig. S3 B). H2O2 treatment also 
induced apoptosis, as judged by the appearance of Annexin 
V–positive and propidium iodide–negative ATDC5 cells, 
which was reversed by NAC (Fig. S3 C). Thus, increased 
ROS inhibit proliferation and induce both chondrocyte 
  hypertrophy and apoptosis. Such changes mediated by H2O2 
were reversed by addition of NAC to the culture. It is as-
sumed that physiologically increasing ROS inhibits prolif-
eration and stimulates the diff  erentiation of proliferating 
chon  dro  cytes into hypertrophic chondrocytes, which even-
tually undergo apoptosis.
During endochondral ossifi  cation, hypertrophic chondro-
cytes induce angiogenesis and mineralization below the hyper-
trophic chondrocyte zone. Mineralization below the growth 
plates was weakly reduced by NAC treatment (unpublished 
data). Collectively, these results indicate that increasing ROS in 
chondrocytes physiologically induce hypertrophy and further 
regulate the apoptosis of chondrocytes, which are followed by 
angiogenesis and mineralization in growth plates.
ROS transduce differentiation signals in chondrocytes 
via ERK and p38 MAPK pathways
To analyze ROS signaling in chondrocyte hypertrophy di-
rectly, we elevated ROS levels by treating ATDC5 cells with 
H2O2 in control medium for 48 h and assayed expression of 
diff  erentiation markers by RT-PCR (Fig. 4 A). H2O2 treat-
ment eff  ectively induced expression of these markers after 48 h 
of culture (Fig. 4 A). Induction of mmp13 by 48 h of treat-
ment with H2O2 was dose dependent (Fig. 4 B). Runx2-
defi  cient mice show defective hypertrophic chondrocyte 
maturation, and forced Runx2 expression induces chondro-
cyte hypertrophy (4, 5, 18, 21). Induction of both mmp13 
and runx2 after treatment with H2O2 for 48 h was inhibited 
by NAC (Fig. 4 C).
It has been reported that the MAPK/ERK activating 
  kinase (MEK)–ERK pathway plays a role in hypertrophic 
diff  erentiation in chondrocytes, whereas p38 signaling is re-
quired for the transition from a prehypertrophic to a com-
pletely hyper  trophic chondrocyte phenotype (for review see 
reference 22). To determine whether elevated ROS directly 
transduce a signal through MAPK pathways, we performed a 
Western blot analysis to analyze phosphorylation of ERK, c-Jun 
N-terminal kinase (JNK), and p38 MAPK in H2O2-treated 
ATDC5 cells. H2O2 treatment induced ERK and p38 MAPK 
phosphorylation but not that of JNK (Fig. 4 D). ERK and 
p38 MAPK but not JNK phosphorylation were also induced 
in ATDC5 cells treated with insulin (Fig. S4, available at 
http://www.jem.org/cgi/ content/full/jem.20062525/DC1). 
Because insulin was added to control medium to yield diff  er-
entiation medium, H2O2 transduced signals similar to those 
mediated by diff  erentiation medium. U016 (an MEK inhibi-
tor that thereby inhibits the ERK pathway) and SB203580 
(a p38 inhibitor) but not SP600125 (a JNK inhibitor) sup-
pressed mmp13 up-regulation by H2O2, indicating that ROS 
transduce a diff  erentiation signal via the ERK and p38 MAPK 
pathways (Fig. 4 E). These results show that elevation of 
ROS in chondrocytes during diff  erentiation activates ERK 
and p38 MAPK, and that activation of these MAPKs is re-
quired for chondrocyte hypertrophy.
Next, we performed metatarsal culture, an ex vivo ex-
plant culture, to examine how ROS elevation induces hyper-
tr  ophy. To do so, we dissected three middle metatarsals from 
the hindlimb of E17.5 mouse embryos and cultured them 
in the presence or absence of H2O2 with or without NAC 
for 5 d. Treatment of metatarsal bones by H2O2 disrupted 
formation of a columnar structure in the prolifer  ating chon-
drocyte zone (Fig. 4 F). Mineralization and apopto  sis of the 
metatarsal bones were also stimulated by H2O2 treatment 
(Fig. S5, available at http://www.jem.org/cgi/content/full/
jem.20062525/DC1).
Growth plates are shown between the dotted lines. (right) Data are mean 
relative numbers ± SD of BrdU-positive chondrocytes in mice treated 
with NAC compared with PBS-treated mice. *, P < 0.01. Bar, 100 μm. 
(D) Three mice were treated subcutaneously with PBS and three were 
treated with NAC (1 g/kg, every 2 d) for 2 wk from the day of birth, and 
angiogenesis was analyzed by PECAM staining. Frozen sections were 
stained with rat anti-PECAM antibody, followed by Alexa Fluor 488–
conjugated goat anti–rat Ig antibody, and were observed under a phase 
contrast (left) or confocal (middle and right) microscopes. Representative 
data are shown. Bar, 50 μm.1618  ROS REGULATE CHONDROGENESIS | Morita et al.
Disruption of the columnar structure in proliferating zones 
and elongated hypertrophic zones in the growth plates 
of Atm−/− mice
Increased ROS levels are detected in various cells in ataxia-
telangiectasia patients (13). Because chondrogenesis in growth 
plates plays a pivotal role in longitudinal growth, we analyzed 
the expression and activation of ATM in chondrocytes from 
growth plates of Atm−/− mice. Phosphorylated ATM, the 
active form of the protein, was detected in growth-plate chon-
drocytes in wild-type mice (Fig. 5 A). Next, we assayed ROS 
concentration in growth-plate chondrocytes. Intracellular ROS 
concentrations, evaluated by dihydroethidium staining, were 
higher in chondrocytes from Atm−/− mice than from wild-
type controls (Fig. 5 B). To analyze whether ROS elevation 
Figure 4.  Elevated ROS induce chondrocyte hypertrophy. (A) ATDC5 
cells were cultured in control medium with 100 μM H2O2 for 1–48 h, and 
expression of the hypertrophic markers type X collagen and mmp13 and 
of internal control β-actin was analyzed by RT-PCR. (B) ATDC5 cells were 
treated with various concentrations of H2O2 in control medium for 48 h, 
and mmp13 and β-actin expression was analyzed by RT-PCR. (C) ATDC5 
cells were cultured in control medium with or without 100 μM H2O2 in 
the presence or absence of 100 μM NAC for 48 h, and mmp13 and runx2 
expression was analyzed by RT-PCR. Blocked up-regulation of mmp13 and 
runx2 by treatment with 100 μM NAC in ATDC5 cells cultured for 48 h 
under 100 μM H2O2-induced oxidative stress conditions was observed. 
(D) ATDC5 cells were starved for 24 h and treated with 100 μM H2O2 for the 
indicated periods. Representative data determined by Western blot analy-
sis are shown among three experiments. H2O2 treatment induced phos-
phorylation of ERK and p38 MAPK but not JNK. (E) ATDC5 cells were 
cultured in control medium with 100 μM H2O2 in the presence or absence 
(vehicle) of an MEK inhibitor (U0126), a p38 MAPK inhibitor (SB203580), 
or a JNK inhibitor (SP600125) for 48 h, and mmp13 and β-actin expres-
sion was analyzed by RT-PCR. Blocked mmp13 up-regulation by the MEK 
or p38 MAPK inhibitor but not by the JNK inhibitor under 100 μM H2O2-
induced oxidative stress conditions was observed. Data were determined 
by RT-PCR. NC, no template control. (F) The effects of elevated ROS on 
chondrogenesis were evaluated in metatarsal bone explants after treat-
ment in the presence or absence of 500 μM H2O2 with or without 500 μM 
NAC for 5 d. Metatarsal bone sections were stained with H&E. Represen-
tative data among three independent experiments are shown. Arrows 
indicate proliferating chondrocyte zones, and proliferating chondrocyte 
zones are highlighted (bottom). Bar, 50 μm. JEM VOL. 204, July 9, 2007  1619
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aff  ects chondrocyte proliferation, we undertook BrdU analysis 
in Atm−/− and wild-type mice. The number of proliferating, 
BrdU-positive chondrocytes was signifi  cantly reduced in 
Atm−/− mice compared with controls (Fig. 5 C), suggesting 
that ROS levels are regulated by ATM in growth-plate chon-
drocytes and that such ROS accumulation may aff  ect chon-
drocyte proliferation in growth plates.
In wild-type mice, proliferating chondrocytes line up along 
the long axis of the bone, which shows a columnar structure 
(Fig. 5 D, highlighted in the small boxes). However, in the 
growth plates of Atm−/− mice, the formation of such columnar 
structures characteristic of proliferating chondrocyte zones is 
disrupted (Fig. 5 D). Proteoglycan synthesis was also reduced, 
and hypertrophic zones were enlarged in Atm−/− mice com-
pared with controls (Fig. 5 D). Induction of vascular endothelial 
cells under the hypertrophic chondrocyte zone and induction 
of apoptosis in hypertrophic chondrocytes were stimulated in 
Atm−/− mice compared with wild-type mice (Fig. S6, available 
at http://www.jem.org/cgi/content/full/jem.20062525/DC1; 
and not depicted). Furthermore, mineralization under the 
growth-plate region, as evaluated by alizarin red staining, 
  increased in Atm−/− compared with control mice (Fig. 5 E). 
Thus, ATM may regulate the process whereby proliferating 
chondrocytes diff  erentiate into hypertrophic chondrocytes.
Increased ROS cause reduced proliferation in chondrocytes 
of Atm−/− growth plates
To determine whether altered chondrogenesis in Atm−/− 
mice is related to oxidative stress, we injected NAC into 
Atm−/− mice every other day from the day of birth until 2 wk 
of age, when animals were analyzed. The high ROS levels 
seen in growth-plate chondrocytes were eff  ectively reduced 
by such treatment in Atm−/− mice (Fig. 6 A). Inhibited pro-
liferation was rescued by NAC treatment in growth-plate 
chondrocytes of Atm−/− mice (Fig. 6 B). The elongated hy-
pertrophic chondrocyte zone seen in the growth plates of 
Atm−/− mice and reduced proteoglycan synthesis were res-
cued by NAC treatment (Fig. 6 C). The increased number of 
apoptotic cells in Atm−/− hypertrophic chondrocytes was also 
signifi  cantly rescued by NAC treatment (Fig. 6 D), as was 
Figure 5.  ATM functions in the development of growth plates. 
(A) Tibial sections of 3-wk-old wild-type mice were stained with rabbit 
antiphosphorylated ATM (pATM) antibody, followed by Alexa Fluor 488–
conjugated anti–rabbit Ig antibody, and observed under a confocal micro-
scope. Nuclei were stained with TOTO3. Representative data are shown. 
Growth plates are indicated between the dotted lines. pATM was detected 
in the chondrocytes of growth plates. Bar, 100 μm. (B) Increased intra-
cellular ROS was detected by dihydroethidium staining in growth-plate 
chondrocytes of 2-wk-old Atm−/− mice compared with those seen in 
wild-type (Atm+/+) mice. Bar, 100 μm. (C) Chondrocyte proliferation was 
evaluated by BrdU staining in 2-wk-old Atm−/− or wild-type (Atm+/+) 
mice. (left) Representative data are shown. (right) Data are mean relative 
numbers ± SD of BrdU-positive cells in Atm−/− compared with Atm+/+ 
chondrocytes. Growth plates are shown between the dotted lines. Atm−/− 
defi  ciency caused defective chondrocyte proliferation. *, P < 0.01. Bar, 
50 μm. (D) Disruption of columnar formation in proliferating zones (P) 
and enlargement of hypertrophic zones (H) were observed in growth plates 
of 3-wk-old Atm−/− compared with Atm+/+ mice by H&E (top) and Alcian 
blue (bottom) staining. Bar, 50 μm. (E) Mineralization was evaluated by 
alizarin red staining in growth plates of 3-wk-old Atm−/− or wild-type 
(Atm+/+) mice. Frozen sections that had not been decalcifi  ed were stained 
with alizarin red. Bar, 100 μm.1620  ROS REGULATE CHONDROGENESIS | Morita et al.
angiogenesis stimulated below the hypertrophic chondrocyte 
zone in Atm−/− mice (Fig. 6 E). Collectively, our fi  ndings 
suggest that elevated intracellular ROS transduce a signal 
suppressing proliferation and induce a hypertrophic state in 
chondrocytes, and that control of ROS levels by ATM is re-
quired for appropriate chondrocyte proliferation and diff  er-
entiation in the growth plate.
D  I  S  C  U  S  S  I  O  N 
Chondrogenesis occurs via three steps: (a) commitment to 
chondrocyte diff  erentiation by mesenchymal cells, seen as 
mesenchymal condensation; (b) chondrocyte proliferation in 
the growth plate to facilitate longitudinal development; and 
(c) diff  erentiation of proliferating chondrocytes to hypertro-
phic chondrocytes (for review see references 1, 2). During 
endochondral ossifi  cation, chondrocyte hypertrophy is critical, 
because cells alter the extracellular matrix and induce vascular 
invasion. Extrinsic factors such as bone morphogenetic pro-
teins, Indian hedgehog, and modulators such as Sox9, Runx2, 
Smads, and histone deacetylase 4 are reportedly essential for 
chondrogenesis (1, 2). Loss of histone deacetylase 4 causes early 
onset of hypertrophy, followed by growth retardation (6). Over-
expression of Runx2 under the control of a type II collagen 
promoter/enhancer induces dwarfi  sm because of precocious 
endochondral ossifi  cation and accelerated chondrocyte dif-
ferentiation (4, 5). Thus, regulation of hypertrophy is critical 
for normal growth (4–6), and abnormalities in chondrocyte 
hypertrophy cause skeletal growth retardation.
We propose that ROS play an essential role as signal 
transducers for chondrocyte hypertrophy. We demonstrate 
that ROS mediated inhibition of proliferation in proliferating 
chondrocytes and induction of hypertrophic chondrocytes. 
Because chondrocyte hypertrophy is associated with apopto-
sis, angiogenesis, and mineralization, regulation of ROS lev-
els in chondrocytes is crucial for normal longitudinal bone 
growth. We show that ROS was specifi  cally elevated in 
chondrocytes during the hypertrophic changes. Chondrocyte 
hypertrophy in ATDC5 cells, a chondrogenic cell line, was 
inhibited by antioxidant NAC treatment, whereas H2O2 
treatment stimulated hypertrophic activity. Inhibition of chon-
drocyte hypertrophy was observed in vivo after administra-
tion of NAC to normal mice, indicating that physiological 
levels of ROS determine chondrocyte hypertrophy. We also 
show that ROS transduced a diff  erentiation signal via ERK 
and p38 MAPK pathways, suggesting that ROS act as a bio-
logical messenger in chondrocyte hypertrophy. Chondrocyte 
apoptosis, angiogenesis, and mineralization were inhibited 
by NAC treatment, suggesting that these events result from 
chondrocyte hypertrophy induced by ROS. To further clar-
ify the in vivo role of ROS in chondrogenesis, we analyzed 
the chondrogenesis of Atm−/− mice, which show higher in-
tracellular accumulation of ROS compared with wild-type 
mice in growth-plate chondrocytes. ATM likely functions in 
oxidative defense by inducing major antioxidative systems, and 
this study shows that ATM loss increased ROS levels in chon-
dro  cytes and induced premature hypertrophy in chondrocytes. 
Because apoptosis is stimulated in the chondrocytes of ATM-
defi  cient mice, elongation of the hypertrophic chondrocyte 
zone in ATM-defi  cient mice is not particularly marked com-
pared with other mutant animals such as MMP13-defi  cient 
mice (19). We demonstrate that in vivo administration of 
NAC to Atm−/− mice down-regulated intracellular H2O2 lev-
els and up-regulated proliferation and proteoglycan synthesis 
in chondrocytes, thereby rescuing premature hypertrophy. 
ROS-induced tissue damage is implicated in diseases such as 
osteoarthritis (23, 24), Alzheimer’s disease (25, 26), and ataxia-
telangiectasia (13) and in aging (27–29) and stem cell dys-
function (14). We underscored a physiological role for ROS 
in chondrocyte hypertrophy and observed abnormalities of 
chondrocyte hypertrophy after an increase in ROS levels.
ROS accumulation is caused by two mechanisms: in-
creased ROS generation and decreased ROS degradation. 
Intracellular ROS may accumulate as a by-product of a high 
cellular metabolism, because proliferating chondrocytes show 
high proliferation activity. In addition, diff  erentiation signals 
induced the expression of nox1, which is responsible for ROS 
production, including H2O2. This suggests that chondrocyte 
hypertrophy was stimulated by the expression of an ROS-
producing gene. Further studies are needed to clarify the sig-
nals responsible for the increased generation of ROS during 
chondrocyte hypertrophy. Meanwhile, it has been shown 
that chondrocyte maturation is accompanied by a progressive 
decrease in catalase activity in the growth cartilage (30). 
Catalase plays key roles in protecting cells from oxidative 
stress by destruction of H2O2. Thus, chondrocyte hyper-
trophy is mediated by intracellular ROS levels, which are 
regulated by ATM. In fact, intracellular ROS were down-
regulated by NAC, which reduced ROS levels in the chon-
drocytes of wild-type and ATM-defi  cient mice, and NAC 
treatment was accompanied by inhibition of chondrocyte 
hypertrophy. Collectively, we conclude that ROS accu-
mulation be  yond threshold levels may initiate inhibition of 
proliferation in late-proliferating chondrocytes and stimu-
late hypertro  phic diff  erentiation.
MATERIALS AND METHODS
Mice.  Animals were purchased from CLEA Japan, kept under pathogen-free 
conditions, and cared for in accordance with the guidelines of Keio Univer-
sity School of Medicine. Pregnant C57BL/6 mice were purchased, and 
embryos between E15.5–17.5 were isolated from the uteri of pregnant females. 
Atm+/− mice were a gift from P.J. Mckinnon (St. Jude Children’s Research 
Hospital, Memphis, TN). Genotyping was performed by PCR-based assays of 
mouse-tail DNA. Littermates served as controls in all experiments.
Cell culture. ATDC5 cells were purchased from the Institute of Physical 
and Chemical Research Cell Bank. Cells were plated at 6 × 104 cells/well in 
six-well plates and cultured in DMEM/Ham’s F12 (1:1; DMEM/F12) me-
dium (Invitrogen) supplemented with 5% FBS (Equitech-Bio, Inc.), 10 μg/ml 
of human transferrin (Roche Molecular Biochemicals), and 3 × 10−8 M 
sodium selenite (Sigma-Aldrich) as control medium, or in 10 μg/ml of human 
transferrin, 3 × 10−8 M sodium selenite, and 10 mg/ml of bovine insulin as 
diff  erentiation medium. Cells were also cultured in DMEM/F12 containing 
5% FBS with various concentrations of H2O2 (Wako) instead of diff  erentia-
tion medium for 48 h. For experiments with NAC and MAPK inhibitors, 
ATDC5 cells were cultured in the presence of 100 μM H2O2 with 500 μM JEM VOL. 204, July 9, 2007  1621
ARTICLE
Figure 6.  Elevated ROS levels cause reduced proliferation and 
an elongated hypertrophic zone in growth plates of Atm−/− mice. 
(A) Three Atm−/− mice were treated subcutaneously with PBS and three 
were treated with NAC (1 g/kg, every 2 d) for 2 wk from the day of birth, 
and intracellular ROS concentration was evaluated by dihydroethidium 
staining in growth plates. Growth plates are shown between the dotted 
lines. (right) Data are mean relative concentrations ± SD of ROS in chon-
drocytes in mice treated with NAC compared with PBS-treated mice. 
Increased intracellular ROS and its reduction by NAC treatment were ob-
served in the chondrocytes of Atm−/− mice. *, P < 0.01. Bar, 100 μm. 
(B) Three Atm−/− mice were treated subcutaneously with PBS and three 
were treated with NAC (1 g/kg, every 2 d) for 2 wk from the day of birth, 
and chondrocyte proliferation was evaluated by BrdU staining. (left) Rep-
resentative data are shown. Growth plates are shown between the dotted 
lines. (right) Data are mean relative numbers ± SD of BrdU-positive 
chondrocytes in Atm−/− mice treated with NAC compared with PBS-
treated Atm−/− mice. *, P < 0.01. Bar, 100 μm. (C) Three Atm−/− mice 
were treated subcutaneously with PBS and three were treated with NAC 
(1 g/kg, every 2 d) for 3 wk from the day of birth, and chondrocyte hyper-
trophy was analyzed by Alcian blue staining. The hypertrophic zone (H) 
was reduced in NAC-treated compared with PBS-treated mice. (left) Rep-
resentative data are shown. (right) Data are mean relative lengths ± SD 
of the hypertrophic zone in Atm−/− growth plates treated with NAC for 
3 wk compared with that of PBS-treated Atm−/− mice. *, P < 0.01. Bar, 
50 μm. (D) Three Atm−/− mice were treated subcutaneously with PBS and 
three were treated with NAC (1 g/kg, every 2 d) for 3 wk from the day of 
birth, and chondrocyte apoptosis was evaluated by TOTO3 nuclear staining. 
The number of apoptotic cells was reduced in NAC-treated compared 
with PBS-treated mice. Data are mean relative numbers ± SD of apop-
totic chondrocytes in Atm−/− mice treated with NAC compared with 
those of PBS-treated Atm−/− mice. *, P < 0.01. (E) Three Atm−/− mice 
were treated subcutaneously with PBS and three were treated with NAC 
(1 g/kg, every 2 d) for 2 wk from the day of birth, and angiogenesis was 
analyzed by PECAM-positive endothelial cells. Frozen sections were 
stained with rat anti-PECAM antibody, followed by Alexa Fluor 488–
conjugated goat anti–rat Ig antibody, and observed by phase contrast 
(left) or confocal (middle and right) microscopes. Representative data are 
shown. Bar, 50 μm.1622  ROS REGULATE CHONDROGENESIS | Morita et al.
NAC (Sigma-Aldrich), 10 μM U0126 (MEK1/2 inhibitor), 10 μM SB203580 
(p38 MAPK inhibitor), or 10 μM SP600125 (JNK inhibitor) for 48 h. To 
analyze apoptosis, ATDC5 cells cultured in the presence or absence of 100 
μM H2O2 with or without 500 μM NAC in control medium for 24 h were 
stained with FITC-conjugated Annexin V and propidium iodide (BD Biosci-
ences) and analyzed by FACSCalibur (Beckton Dickinson).
Metatarsal culture. Three middle metatarsals of each hindlimb of E17.5 
mouse embryos were dissected and cultured for 5 d on a culture plate insert 
(Millicell; Millipore) in 1 ml BGJb medium (Invitrogen) supplemented with 
10% FCS. 500 μM H2O2 was added with or without 100 μM NAC. After 
cultivation, metatarsals were fi  xed in 4% paraformaldehyde/PBS, embedded in 
paraffi   n, sectioned to 4 μm, and stained with hematoxylin and eosin (H&E).
Analysis of intracellular ROS. Cell samples were either stained with 
DCF-DA (Sigma-Aldrich) at 4°C for 30 min and analyzed by FACSCalibur 
or loaded with 5 μM DCF-DA and incubated on a shaker at 37°C for 30 min. 
The peak excitation and emission wavelengths for oxidized DCF were 488 
and 525 nm, respectively. For dihydroethidium staining, the forelimb of 
E17.5 mouse embryos was dissected, embedded in minced rat liver, and fro-
zen in 2-methylbutane (Sigma-Aldrich) plus liquid nitrogen. Frozen sections 
of forelimb that had not been decalcifi  ed were cut on a cryostat (model 
HM505; MICROME), stained with dihydroethidium (Invitrogen) at room 
temperature for 30 min, and observed under a confocal microscope (FV1000; 
Olympus). ROS production in chondrocytes was quantifi  ed by signal intensity 
using a confocal image analyzer (FV10-ASW; Olympus).
Immunohistochemical analysis.  Tibias were dissected from 2–3-wk-old 
Atm−/− or control mice treated with or without PBS or NAC (1 g/kg, every 
2 d) for 2–3 wk. Frozen sections that had not been decalcifi  ed were prepared 
as previously described (31). Specimens were stained with antiphosphory-
lated ATM antibody (Rockland), followed by Alexa Fluor 488–conjugated 
goat anti–rabbit IgG antibody (Invitrogen) and TOTO3 (Invitrogen) for 
nuclear staining. For BrdU staining, 200 μl BrdU solution was injected into 
the peritoneal cavity of 2-wk-old Atm−/− or control mice. Mice were killed 
2.5 h after injection, and the tibias were extracted. Frozen sections were pre-
pared as previously described (31) and subjected to BrdU immunohisto-
chemistry analysis (Calbiochem). Fluorescent images were obtained using a 
confocal laser scanning microscope. For H&E and Alcian blue staining, tibias 
were dissected from 3-wk-old Atm−/− or control mice treated with or with-
out PBS or NAC (1 g/kg, every 2 d) for 3 wk, fi  xed in 10% formalin, decal-
cifi  ed, embedded in paraffi   n, and cut into 4-μm sections. Deparaffi   nized 
sections of paraffi   n-embedded samples were stained with H&E (Muto Pure 
Chemical Co. Ltd.) or Alcian blue (Sigma-Aldrich).
Western blot analysis. ATDC5 cells were starved in control medium 
without FBS for 12 h and stimulated with 100 μM H2O2 for various minutes. 
Cell lysates were collected, and Western blot analysis was performed using 
polyclonal antibodies to detect ERK, phosphorylated ERK, p38 MAPK, 
phosphorylated p38 MAPK, JNK, and phosphorylated JNK. All antibodies 
were obtained from Cell Signaling Technology.
RT-PCR.  Total RNA was extracted from cultured ATDC5 cells, and cDNA 
was synthesized by RT. RT-PCR analysis was performed using the follow-
ing primer sets: mmp13-sense, 5′-A  G  A  A  G  T  C  T  A  C  A  G  T  G  A  C  C  T  C  C  A  C  A  G-
T  T  -3′; mmp13-antisense, 5′-G  A  C  T  C  T  C  A  C  A  A  T  G  C  G  A  T  T  A  C  T  C  C  -3′; 
type X collagen–sense, 5′-T  T  C  A  T  G  G  G  A  T  G  T  T  T  T  A  T  G  C  T  G  A  A  C  G  -3′; type X 
collagen–antisense, 5′-T  T  T  A  G  G  T  C  C  T  T  G  G  G  G  T  C  C  C  A  T  A  T  T  C  -3′; runx2-
sense, 5′-A  G  A  A  G  G  C  T  C  T  G  G  C  G  T  T  T  A  A  A  T  G  G  T  T  -3′; runx2-antisense, 
5′-A  A  A  A  G  G  A  C  T  T  G  G  T  G  C  A  G  A  G  T  T  C  A  G  G  -3′; β-actin–sense, 5′-T  C  G-
T  G  C  G  T  G  A  C  A  T  C  A  A  A  G  A  G  -3′; and β-actin–antisense, 5′-T  G  G  A  C  A  G  T  G-
A  G  G  C  C  A  G  G  A  T  G  -3′.
Statistical analysis. p-values were calculated by the unpaired Student’s 
t test.
Online supplemental material. Fig. S1 shows the expression of nox1 in 
chondrocytes. Fig. S2 shows the Safranin-O staining of chondrocytes in 
mice treated with PBS or NAC. Fig. S3 shows the induction of chondrocyte 
apoptosis by ROS. Fig. S4 shows the activation of MAPKs by insulin in 
chondrocytes. Fig. S5 shows the induction of mineralization and apoptosis in 
chondrocytes by ROS. Fig. S6 shows the chondrocyte apoptosis in ATM-
defi  cient mice. Online supplemental material is available at http://www.jem
.org/cgi/content/full/jem.20062525/DC1.
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